Indaptus Therapeutics, Inc. [Rocket]

Overview

Indaptus Therapeutics, Inc.

Add to portfolio

Recent News + Filings (All items)

Date Filed	Type	Description
08/16/2023	4	Anderson Glen R. (10% Owner) has filed a Form 4 on Indaptus Therapeutics, Inc.
08/14/2023	10-Q	Quarterly Report for the period ended June 30, 2023
08/14/2023	8-K	Quarterly results
08/10/2023	8-K	Other Events  Interactive Data
08/07/2023	4	Waltzman Roger J. (Chief Medical Officer) has filed a Form 4 on Indaptus Therapeutics, Inc.
08/07/2023	3	Waltzman Roger J. (Chief Medical Officer) has filed a Form 3 on Indaptus Therapeutics, Inc.
05/25/2023	8-K	Submission of Matters to a Vote of Security Holders  Interactive Data

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20
Revenues	0.0	0.0	0.0
Cost of goods sold	0.0	0.0	0.0
Gross profit	0.0	0.0	0.0
Research and development	6.3	2.5	2.7
General and administrative	8.6	5.2	0.9
EBIT	-14.9	-7.7	-3.6
Pre-tax income	-14.3	-7.7	-3.6
Income taxes	0.0	0.0	0.0
Net income	-14.3	-7.7	-3.6

Diluted EPS	($1.73)	($1.89)	($1.84)
Shares outstanding (diluted)	8.3	4.1	1.9

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy